Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

We evaluated the prognostic and predictive value of a range of molecular changes in the setting of a randomised trial comparing standard PCV (procarbazine, CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) and vincristine) chemotherapy with the standard temozolomide (TMZ) 5-day (200 mg/m(2)/day) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Vincent Peter, Ichimura, Koichi, Di, Ying, Pearson, Danita, Chan, Ray, Thompson, Lindsay C, Gabe, Rhian, Brada, Michael, Stenning, Sally P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229733/
https://www.ncbi.nlm.nih.gov/pubmed/24952577
http://dx.doi.org/10.1186/2051-5960-2-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229733/
https://www.ncbi.nlm.nih.gov/pubmed/24952577
http://dx.doi.org/10.1186/2051-5960-2-68

Ejemplares similares